Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis

医学 支气管动脉 栓塞 外科 肺结核 存活率 动脉 放射科 病理
作者
Jung Han Hwang,Jeong Ho Kim,Suyoung Park,Ki Hyun Lee,So Hyun Park
出处
期刊:Respiratory Research [BioMed Central]
卷期号:22 (1) 被引量:20
标识
DOI:10.1186/s12931-021-01820-x
摘要

To evaluate the safety, efficacy, and long-term outcome of bronchial artery embolization (BAE) in the treatment of non-massive hemoptysis and the prognostic factors associated with recurrent bleeding.From March 2005 to September 2014, BAE was performed in 233 patients with non-massive hemoptysis. All patients had a history of persistent or recurrent hemoptysis despite conservative medical treatment. We assessed the technical and clinical success, recurrence, prognostic factors related to recurrent bleeding, recurrence-free survival rate, additional treatment, and major complications in all the patients.Technical success was achieved in 224 patients (96.1%), and clinical success was obtained in 219 (94.0%) of the 233 patients. In addition, 64 patients (27.5%) presented hemoptysis recurrence with median time of 197 days after embolization. Tuberculosis sequelae and presence of aberrant bronchial artery or non-bronchial systemic collaterals were significantly related to recurrent bleeding (p < 0.05). The use of Histoacryl-based embolic materials significantly reduced the recurrent bleeding rate (p < 0.05). Patient who had a tuberculosis sequelae showed a significantly lower recurrence-free survival rate (p = 0.013). Presence of aberrant bronchial artery or non-bronchial systemic collaterals showed a statistically significant correlation with recurrence-free survival rate (p = 0.021). No patients had major complications during follow-up.BAE is a safe and effective treatment to manage non-massive hemoptysis. The procedure may offer a better long-term control of recurrent hemoptysis and quality of life than conservative therapy alone.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
打怪完成签到,获得积分10
1秒前
pluto的应助被拓跋平萱采纳,获得10
1秒前
郭浩瑞发布了新的文献求助10
2秒前
793967195完成签到,获得积分10
2秒前
莱十一发布了新的文献求助10
2秒前
馒头发布了新的文献求助10
3秒前
mm发布了新的文献求助10
4秒前
Akim的应助被369ninja采纳,获得10
4秒前
4秒前
顾矜的应助被Anvil采纳,获得10
4秒前
5秒前
Double完成签到 ,获得积分10
5秒前
6秒前
Lomungii发布了新的文献求助10
6秒前
6秒前
6秒前
6秒前
杜99完成签到,获得积分10
7秒前
ppzzqq123完成签到,获得积分20
7秒前
深情安青的应助被南州采纳,获得10
8秒前
9秒前
10秒前
衣衣衣发布了新的文献求助10
11秒前
Galaxy发布了新的文献求助10
11秒前
12秒前
12秒前
务实的忆雪的应助被菠菠采纳,获得10
12秒前
Lyy完成签到,获得积分10
12秒前
领导范儿的应助被xlanister采纳,获得10
13秒前
jenny发布了新的文献求助10
13秒前
13秒前
情怀的应助被xiongjie采纳,获得10
14秒前
14秒前
林狗完成签到,获得积分0
14秒前
自然的代亦完成签到,获得积分10
15秒前
15秒前
小马甲的应助被幽默的小松鼠采纳,获得10
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184336
求助须知:如何正确求助?哪些是违规求助? 9573358
关于积分的说明 21830993
捐赠科研通 7781367
什么是DOI,文献DOI怎么找? 3434307
关于科研通互助平台的介绍 2558401
邀请新用户注册赠送积分活动 2480846